Mid-Year Report — CANGENE CORPORATION for CANGENE CORPORATION (2007)

Firm

CANGENE CORPORATION

Client

CANGENE CORPORATION

Income

—

Expenses

—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Monitor legislation regarding biodefense vaccines, biodefense therapeutics, and pandemic preparedness. Discuss possible legislation addressing procurement processes for Project BioShield and legislation addressing the Biologics Price Competition and Innovation Act of 2007.

Lobbyist	Covered position, as disclosed
CARLA BOTTING	N/A
DON STEWART	N/A
ANDREW STOREY	N/A

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); Congressional Budget Office (CBO)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.